期刊文献+

微RNA-449a在胃癌中的表达及其功能研究 被引量:2

Expression and function of miRNA-449a in gastric cancer
下载PDF
导出
摘要 目的探讨微RNA(miRNA)-449a在胃癌中的表达及其功能。方法采用逆转录荧光定量聚合酶链式反应PCR)检测miRNA-449a在胃癌组织和配对的正常组织中的表达,分析miRNA-449a与临床病理参数之间的关系。并将miRNA-449a模拟物转染胃癌细胞后进行细胞增殖分析。结果 74.63%的癌组织中miRNA-449a表达下降,miRNA-449a在胃癌组织中的表达明显低于配对正常组织,差异有统计学意义(t=2.04,P<0.05)。miRNA-449a表达在胃癌的肿瘤大小和胃癌临床分期(TNM)各组间均存在明显差异,差异有统计学意义(χ2分别=9.69、9.41,P均<0.05),而miRNA-449a表达在不同性别和年龄之间的差异均无统计学意义(χ2分别=0.04、0.01,P均>0.05)。与阴性对照比较,miRNA-449a模拟物明显抑制胃癌细胞的增殖,差异有统计学意义(t=21.67,P<0.05)。结论 miRNA-449a在胃癌组织中呈低表达,抑制胃癌细胞增殖,可能发挥抑癌基因的作用。 Objective To investigate the expression and function of miRNA-449a in gastric cancer. Methods The expression of miRNA-449a in gastric cancer tissues and matched normal tissues were detected by real time PCR. And the relationship between clinical characteristics and the level of miRNA-449a was analysed. CCK8 assay was applied to analyze the proliferation after transfecting mimics of miRNA-449a into gastric cancer cells. Results 74.63% miRNA-449a expression in gastric cancer tissues was reduced. Compared with the matched normal tissues, miRNA-449a expression was significantly lower in gastric cancer tissues(t=2.04,P〈0.05). There were significant differences of miRNA-449a expression in different tumor volume and different TNM stage (X2=9.69,9.41 ,P〈0.05). But it had no significant correlation between miRNA-449a and sex, age (X2=0.04,0.01,P〉0.05). Compared with negative control, miRNA-449a mimics could repress proliferation of gastric cancer cells (t=21.67,P〈0.05). Conclusions miRNA-449a was down-regulated expression in gastric cancer and repressed cell proliferation, which maybe play a role as a tumor suppressor gene.
出处 《全科医学临床与教育》 2013年第2期135-137,共3页 Clinical Education of General Practice
基金 温岭市科学技术局资助项目(温科〔2012〕12-95)
关键词 胃癌 miRNA-449a gastric cancer miRNA-449a
  • 相关文献

参考文献1

二级参考文献24

  • 1[1]Ambros V.microRNAs:tiny regulators with great potential.Cell 2001; 107:823-826
  • 2[2]Ambros V.The functions of animal microRNAs.Nature 2004;431:350-355
  • 3[3]Bartel DP.MicroRNAs:genomics,biogenesis,mechanism,and function.Cell 2004; 116:281-297
  • 4[4]Zhang L,Huang J,Yang N,Greshock J,Megraw MS,Giannakakis A,Liang S,Naylor TL,Barchetti A,Ward MR,Yao G,Medina A,O'brien-Jenkins A,Katsaros D,Hatzigeorgiou A,Gimotty PA,Weber BL,Coukos G.microRNAs exhibit high frequency genomic alterations in human cancer.Proc Natl Acad Sci USA 2006; 103:9136-9141
  • 5[5]Rajewsky N.microRNA target predictions in animals.Nat Genet 2006; 38 Suppl:S8-S13
  • 6[6]Lagos-Quintana M,Rauhut R,Lendeckel W,Tuschl T.Identification of novel genes coding for small expressed RNAs.Science 2001; 294:853-858
  • 7[7]Bonnet E,Van de Peer Y,Rouze P.The small RNA world of plants.New Phytol 2006; 171:451-468
  • 8[8]Reinhart BJ,Weinstein EG,Rhoades MW,Bartel B,Bartel DP.MicroRNAs in plants.Genes Dev 2002; 16:1616-1626
  • 9[9]miRBase Sequence database.http://microrna.sanger.ac.uk/sequences/index.shtml (Version current at August 9,2006)
  • 10[10]Zamore PD,Haley B.Ribo-gnome:the big world of small RNAs.Science 2005; 309:1519-1524

共引文献47

同被引文献25

  • 1Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. Cancer J Clin,2011,61(2): 69-90.
  • 2Negrini M,Ferracin M,Sabbioni S,et al. MicroRNAs in human cancer: from research to therapy[J]. J Cell Sci, 2007,120(Ptl 1): 1833-1540.
  • 3Krutzfeldt J,Rajewsky N,Braich R,et al. Silencing of microRNAs in vivo with antagomirs[J]. Nature, 2005,438 (7068): 685-689.
  • 4Perez R,Wu N,Klipfel AA,et al. A better cell cycle target for gene therapy of eolorectal cancer: cyclin G[J].J Gastrointest Surg,2003,7(7): 884-889.
  • 5Llave C,Xie Z,Kasschau KD, et al. Cleavage of Scare- crow-like mRNA targets directed by a class of Ara- bidopsis miRNA[J].Science,2002,297(5589): 2053-2056.
  • 6Calin GA,Croce CM. MicroRNA signatures in human cancers[J]. Nat Rev Cancer,2006,6(ll): 857-866.
  • 7Ma L,Liu J,Shen J,et al. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells[J].Cancer Biol Ther,2010,9(7): 554-561.
  • 8Gramantieri L,Ferracin M,Fornari F,et al. Cyclin G1 is a target of miR-122a,a microRNA frequently down-regulated in human hepatocellular carcinoma[J].Cancer Res, 2007,67(13): 6092-6099.
  • 9Kutay H, Bai S, Datta J,et al. Downregulation of miR- 122 in the rodent and human hepatocellular carcinomas[J]. J Cell Biochem,2006,99(3): 671-678.
  • 10Okamoto K,Beach D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein[J]. Embo J, 1994, 13(20) :4816-4822.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部